AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Bill Tracker · New Mexico

SB219

Medical Psilocybin Act

Status

Enacted

2025 Regular Session

IntroducedDate TBC (done)
PassedMar 18, 2025 (done)
SignedApr 7, 2025 (done)
Law in effectNext step (current)

Sponsor: Craig Brandt (Republican)
Type: Therapeutic Access
Substances: Psilocybin
Session dates: January 21, 2025 – March 22, 2025

Official text

Summary (from PoliPsy)

Medical Psilocybin Act

The full bill text and every version are kept by the legislature. We link to it rather than copy it so readers always see the current version.

Read the full bill text

Source: nmlegis.gov

Legislative history

April 7, 2025
Passed
April 7, 2025
Passed
April 7, 2025
Signed into Law
March 18, 2025
Enrolled (Passed Both Chambers)
March 17, 2025
Committee Report
March 12, 2025
Engrossed (Passed One Chamber)
March 10, 2025
Committee Report
March 6, 2025
Committee Report
February 12, 2025
Committee Report
January 30, 2025
Introduced

Loading bill…